Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II trial of inhaled H057 in adults with moderate to severe community-acquired pneumonia
CTR20253790Phase 2Active
- Sponsor
- Shanghai Huilun Pharmaceutical Co., Ltd.
- Start
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of H-057 in community-acquired pneumonia (CAP), sponsored by Shanghai Huilun Pharmaceutical Co., Ltd.. Started Sep 2025; status: active.
02
Drugs
H-057
03
Conditions
community-acquired pneumonia (CAP)
Beyond the preview
Go deeper on CTR20253790.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20253790.